About ICON, Ireland
ICON, Ireland: A Global Leader in Outsourced Development and Commercialisation Services
ICON is a leading global provider of outsourced development and commercialisation services to the pharmaceutical, biotechnology, and medical device industries. With over 25 years of experience in the industry, ICON has established itself as a trusted partner for companies looking to bring their products to market quickly and efficiently.
Headquartered in Dublin, Ireland, ICON has a global presence with operations in over 40 countries. The company employs more than 15,000 professionals worldwide who are dedicated to providing high-quality services that meet the unique needs of each client.
At ICON, we understand that every project is different. That's why we offer a wide range of services that can be tailored to meet the specific needs of our clients. Our services include clinical research and development, regulatory consulting and strategy, pharmacovigilance and safety management, medical imaging analysis, patient engagement solutions as well as commercialisation support.
Our clinical research team provides end-to-end support for all phases of drug development from early-phase studies through post-marketing surveillance. We have extensive experience conducting trials across all therapeutic areas including oncology/hematology; cardiovascular/metabolic; infectious diseases/vaccines; neurology/psychiatry; respiratory/allergy/inflammation; ophthalmology/dermatology.
Our regulatory consulting team provides strategic advice on regulatory requirements for product approval across various regions globally including FDA (US), EMA (Europe), PMDA (Japan) among others. We also provide assistance with preparation of regulatory submissions such as INDs/CTAs/NDA/BLA filings etc., ensuring compliance with local regulations while minimizing delays in approvals.
Our pharmacovigilance team ensures patient safety by monitoring adverse events associated with drugs/devices throughout their lifecycle from pre-clinical studies through post-marketing surveillance. We provide comprehensive safety management solutions including signal detection & evaluation activities along with risk management plans & benefit-risk assessments.
We also offer medical imaging analysis services which help our clients make informed decisions about their products by providing accurate data on efficacy endpoints such as tumor response rates or disease progression-free survival rates using advanced imaging techniques like MRI/PET scans etc., thereby reducing time-to-market while improving outcomes for patients.
Patient engagement solutions are another area where we excel at ICON - we work closely with patients throughout the drug development process by engaging them early on during protocol design phase through advisory boards or focus groups so that they can provide valuable insights into what matters most when it comes to treatment options available today vs tomorrow!
Finally our commercialization support team helps clients navigate complex market access challenges by providing strategic advice on pricing/reimbursement strategies along with launch planning activities such as KOL identification & engagement programs etc., thereby ensuring successful product launches globally!
In conclusion,
ICON is an industry leader when it comes to outsourced development and commercialization services for pharmaceuticals/biotech devices companies worldwide! With its vast experience spanning over two decades coupled together its highly skilled workforce spread across multiple geographies makes it an ideal partner for any company looking forward towards bringing innovative therapies/devices faster into markets while maintaining highest standards possible!